Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

King Michael N. — Edge Therapeutics, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / King Michael N.

King Michael N.

Interim CFO at Edge Therapeutics, Inc. · on record since Jul 6, 2020

Insider trading activity of King Michael N.

Transactions on record: 1; since Dec 9, 2020

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Dec 9, 2020

Figures computed from official regulatory filings — methodology.

Companies where King Michael N. has traded

Edge Therapeutics, Inc.1 tx · Dec 9, 2020

Track record of King Michael N.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of King Michael N.

Co-insiders of King Michael N.

Ali-Jackson KamilEdge Therapeutics, Inc.
BARER SOL JEdge Therapeutics, Inc.
BEDU-ADDO FRANKEdge Therapeutics, Inc.
BLECH ISAACEdge Therapeutics, Inc.
Bloomquist DeLyle WEdge Therapeutics, Inc.
Boesgaard LarsEdge Therapeutics, Inc.
BRAWLEY OTIS WEdge Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

BRENNAN DANIELEdge Therapeutics, Inc.

Brown Spencer D.Edge Therapeutics, Inc.

CONN GREGORYEdge Therapeutics, Inc.

Conti Kurt GEdge Therapeutics, Inc.

Crane Rosemary AEdge Therapeutics, Inc.

Einhorn Andrew J.Edge Therapeutics, Inc.

Faleck Herbert JEdge Therapeutics, Inc.

Freitag Gregory GeneEdge Therapeutics, Inc.

Glover Steve CEdge Therapeutics, Inc.

HEALY JAMESEdge Therapeutics, Inc.

HILL MATHEW CEdge Therapeutics, Inc.

Hove Anders DEdge Therapeutics, Inc.

Iliev IlianEdge Therapeutics, Inc.

Leuthner Brian AEdge Therapeutics, Inc.

LOUGHLIN JAMES JEdge Therapeutics, Inc.

Macdonald R. LochEdge Therapeutics, Inc.

MARCHIO ALBERT N IIEdge Therapeutics, Inc.

MIDDLEKAUFF W BRADFORDEdge Therapeutics, Inc.

New Leaf Venture Associates III, L.P.Edge Therapeutics, Inc.

New Leaf Venture Management III, L.L.C.Edge Therapeutics, Inc.

New Leaf Venture Partners, L.L.C.Edge Therapeutics, Inc.

New Leaf Ventures III, L.P.Edge Therapeutics, Inc.

Ratcliffe LiamEdge Therapeutics, Inc.

Saik AndrewEdge Therapeutics, Inc.

Shepard Kirk V.Edge Therapeutics, Inc.

Spiegel Robert J.Edge Therapeutics, Inc.

SYKES RICHARDEdge Therapeutics, Inc.

Toutain StephanEdge Therapeutics, Inc.

Trochimiuk JanettaEdge Therapeutics, Inc.

Vaish RenuEdge Therapeutics, Inc.

VAN VOORHEES SETHEdge Therapeutics, Inc.

WOOD LAURENEdge Therapeutics, Inc.

Wyant AlyssaEdge Therapeutics, Inc.

Yaman AlpaslanEdge Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Edge Therapeutics, Inc.	Dec 9, 2020	AwardD	50,000	0.00 USD	$0	SEC